NDC 0074-2306-70
Rinvoq 15 mg/1
Upadacitinib · TABLET, EXTENDED RELEASE
Rinvoq is a tablet, extended release containing upadacitinib at a strength of 15 mg/1. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- Rinvoq
- Generic Name
- Upadacitinib
- NDC Code (Package)
0074-2306-70- NDC Code (Product)
0074-2306- Manufacturer
- AbbVie Inc.
- Strength
- 15 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA211675
- Drug Class
- Janus Kinase Inhibitor [EPC]
- Marketing Start
- 08/16/2019
Recall History
No Recall HistoryView Full Drug Page
Rinvoq — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.